What YD Bio Ltd's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 3 | 3 |
| Sells | 0 | 0 |
| Total trades | 5 | 9 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 9 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Chang Kochi | Director | Sep 30 | Exercise / conversion · M | +3,135 | — | — | 10,965 |
| Lu Shao-Ta | Director | Sep 30 | Exercise / conversion · M | +3,135 | — | — | 10,965 |
| Shen Ethan PhD | CEO | Sep 14 | Open-market buy · P | +12,700 | $3.85 | +$48.9K | 11,258,331 |
| Shen Ethan PhD | CEO | Sep 09 | Open-market buy · P | +3,100 | $3.93 | +$12.2K | 11,245,631 |
| Shen Ethan PhD | CEO | Sep 04 | Open-market buy · P | +18,378 | $3.67 | +$67.4K | 11,242,531 |
| Chang Kochi | Director | Jun 30 | Exercise / conversion · M | +5,749 | — | — | 7,830 |
| Lu Shao-Ta | Director | Jun 30 | Exercise / conversion · M | +5,749 | — | — | 7,830 |
| Chang Kochi | Director | Mar 31 | Exercise / conversion · M | +2,081 | — | — | 2,081 |
| Lu Shao-Ta | Director | Mar 31 | Exercise / conversion · M | +2,081 | — | — | 2,081 |
Loading...
